CDMOs offering Upstream Processing with Gene Therapy
23 published
23 published CDMOs match Upstream Processing and Gene Therapy.
Locations in this set include United States, United Kingdom, China, Japan, Canada, and Denmark.
Capabilities that show up most often in this set: Downstream Processing, CMC Analytical Development, Process Development, Viral Vector Manufacturing, and Cell-Line Development.
Matching companies
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Yapan BioYapan Bio provides integrated process development, characterization, and GMP manufacturing for vaccines, monoclonal antibodies, gene therapy, and viral vector-based biologics, with capabilities up to 1000L bioreactor scale and BSL-2+ containment.
Markdown mirror: /explore/upstream-processing/gene-therapy.md